Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
QuantuMDx logo — Transforming Point of Need Multiplex Diagnostics

QuantuMDx

Transforming Point of Need Multiplex Diagnostics

Founded 2008 United Kingdom Newcastle Upon Tyne, United Kingdom 59 employees Venture round Total: $59.77M Biotechnology, Health Care +1

General Information

Company Name QuantuMDx
Founded Year 2008
Location United Kingdom Newcastle Upon Tyne, United Kingdom
Employees 59
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with QuantuMDx. To contact QuantuMDx, visit quantumdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does QuantuMDx compare?

A PDF of QuantuMDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting QuantuMDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About QuantuMDx

QuantuMDx, founded in 2008, is a forward-thinking MedTech company headquartered in the United Kingdom. With a commitment to innovation in the fields of Biotechnology, Health Care, and Pharmaceutical, the company is dedicated to advancing multiplex molecular diagnostic solutions under its slogan, "Transforming Point of Need Multiplex Diagnostics."

QuantuMDx leverages leading-edge technology to produce diagnostic tools designed for immediate application at the point of need, which aligns with current market trends favoring rapid diagnostics. Their approach positions them uniquely in a competitive field, fostering potential disruptive impact within healthcare delivery systems globally.

The company last secured a £15.00M Venture Round of investment on 08 November 2021 from the Vita Spring IVD Fund. This financing underscores investor confidence in QuantuMDx's mission and innovative capability.

Business keywords: MedTech, Molecular Diagnostics, Point of Need Diagnostics, Hand-held Diagnostic Devices, Low Cost Diagnostics, Genomic Sequencing, Personalised Medicine, Portable Diagnostic Platforms, COVID-19 Diagnostics, DNA Extraction, Rapid Diagnostics, Respiratory Infections, Sexually Transmitted Infections, In Vitro Diagnostics, Assay Development

Services & Products

Rapid Multiplex PCR Testing
Point-of-Care Diagnostic Devices
Development of Diagnostic Assays
Healthcare and Laboratory Solutions

Target Customers

Healthcare Professionals Clinical Setting Managers Laboratory Professionals Testing Providers

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £15.00M 1
Vita Spring IVD Fund
08 Nov 2021
Debt Financing £11.00M 1
The Future Fund
24 Mar 2021
Debt Financing £10.00M -
27 Jan 2020
Venture Round £1.00M 1
3B Future Health Fund
3B Future Health Fund
01 Nov 2017
Venture Round £264.00K 1
3B Future Health Fund
3B Future Health Fund
01 Jun 2017
Venture Round £2.00M 1
3B Future Health Fund
3B Future Health Fund
01 Sep 2016
Venture Round $8.42M -
02 Jun 2014
Grant $1.79M -
18 Oct 2013
Grant £1.40M -
05 Nov 2012
Grant $5.70M -
26 Sep 2012

View All 12 Funding Rounds

QuantuMDx Alternatives & Competitors

View All Alternatives
QuantuMDx vs
Thrixen
Thrixen Singapore

Unlocking the next generation of simple, affordable & accessible diagnostics

Venture round
10 employees
Biotechnology, Health Care
QuantuMDx vs
Omini
Omini France

Multiplex blood testing platform to monitor chronic diseases like heart failure Project co-funded by...

58 employees
Biotechnology, Health Care
QuantuMDx vs
G2M | Next Generation IVD solutions for Genomics
G2M | Next Generation IVD solutions for Genomics India

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
View all alternatives

FAQ About QuantuMDx

Transforming Point of Need Multiplex Diagnostics
QuantuMDx was founded in 2008.
QuantuMDx is headquartered in Newcastle Upon Tyne, United Kingdom.
QuantuMDx operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on MedTech, Molecular Diagnostics, Point of Need Diagnostics and Hand-held Diagnostic Devices. Its customers include Healthcare Professionals, Clinical Setting Managers and Laboratory Professionals.
QuantuMDx has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
QuantuMDx has approximately 59 employees.
QuantuMDx has completed 12 funding rounds, raising a total of $59.77M. The latest funding stage is Venture round.
QuantuMDx offers: Rapid Multiplex PCR Testing, Point-of-Care Diagnostic Devices, Development of Diagnostic Assays, Healthcare and Laboratory Solutions.
Top alternatives and competitors to QuantuMDx include Thrixen, Omini, G2M | Next Generation IVD solutions for Genomics, Quidel, Anatolia Geneworks. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QuantuMDx and Thrixen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for QuantuMDx, https://bouncewatch.com/company/quantumdx, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes